MyFinsight
Home
About
Contact
kpti: the income statement
Download
Download image
Net loss
-$33,127K
(-3.29%↓ Y/Y)
Gross product revenue
$44,163K
Income tax provision
$34K
(21.43%↑ Y/Y)
Loss before income
taxes
-$33,093K
(-3.27%↓ Y/Y)
License And Other
$12,012K
Product
$32,032K
Provisions for product
revenue
$12,131K
Total other (expense)
income, net
-$17,873K
(-210.24%↓ Y/Y)
Loss from operations
-$15,220K
(42.09%↑ Y/Y)
Interest income
$553K
(-69.81%↓ Y/Y)
Revenue from contract
with customer,...
$44,044K
(13.57%↑ Y/Y)
Other (expense)
income, net
-$7,418K
(-295.62%↓ Y/Y)
Interest expense
$11,008K
(-3.31%↓ Y/Y)
Total operating
expenses
$59,264K
(-8.92%↓ Y/Y)
Selling, general and
administrative
$26,607K
(-3.71%↓ Y/Y)
Research and development
$30,544K
(-15.47%↓ Y/Y)
Cost of
sales-Product
$2,113K
Back
Back
Income Statement
source: myfinsight.com
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)